ORPHAZYME A/S TO PRESENT AT COWEN & CO ANNUAL HEALTH CARE CONFERENCE

Copenhagen, Denmark, March 11, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that Anders Hinsby, Chief Executive Officer at Orphazyme, will be presenting at the Cowen & Co Annual Health Care Conference in Boston, MA, USA on March 12, 2019.